Arbor Rapha Capital Bioholdings Corp. I (ARCKU) Prices $150M IPO


Arbor Rapha Capital Bioholdings Corp. I (ARCKU) Prices $150M IPO

Oct 28, 2021 IPOs by Marlena Haddad

Arbor Rapha Capital Bioholdings Corp. I  announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ARCKU” Friday, October 29.

The new SPAC intends to search for companies in the biopharmaceutical sector, with a focus on disruptive technologies with the potential to transform healthcare and dramatically improve the lives of patients. Arbor Rapha Capital Bioholdings I is led by CEO and President Ivan Kaufman, CSO Kevin Slawin, CFO Paul Elenio, Secretary & VP William Connolly, and Treasurer John Natalone.

Total SPAC deal count for 2021 year-to-date is now 500. This offering is expected to close on Tuesday, November 2.

Cantor Fitzgerald & Co. (“Cantor”) is acting as sole book-running manager. Skadden, Arps, Slate, Meagher & Flom LLP is serving as Issuer’s Counsel with Ellenoff Grossman & Schole LLP serving as Underwriter’s Counsel.  Marcum LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.